210 related articles for article (PubMed ID: 33741354)
1. Structural and dynamic characterization of the C-terminal tail of ErbB2: Disordered but not random.
Pinet L; Wang YH; Deville C; Lescop E; Guerlesquin F; Badache A; Bontems F; Morellet N; Durand D; Assrir N; van Heijenoort C
Biophys J; 2021 May; 120(10):1869-1882. PubMed ID: 33741354
[TBL] [Abstract][Full Text] [Related]
2. Transient structure and SH3 interaction sites in an intrinsically disordered fragment of the hepatitis C virus protein NS5A.
Feuerstein S; Solyom Z; Aladag A; Favier A; Schwarten M; Hoffmann S; Willbold D; Brutscher B
J Mol Biol; 2012 Jul; 420(4-5):310-23. PubMed ID: 22543239
[TBL] [Abstract][Full Text] [Related]
3.
Wang Y; Pinet L; Assrir N; Elantak L; Guerlesquin F; Badache A; Lescop E; van Heijenoort C
Biomol NMR Assign; 2018 Apr; 12(1):23-26. PubMed ID: 28905237
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
Lu Y; Zi X; Zhao Y; Pollak M
Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
[TBL] [Abstract][Full Text] [Related]
5. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. I. Activation of protein kinase C stimulates tyrosine phosphorylation and activation of ErbB2 and ErbB3.
Emkey R; Kahn CR
J Biol Chem; 1997 Dec; 272(49):31172-81. PubMed ID: 9388271
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions.
Merő B; Radnai L; Gógl G; Tőke O; Leveles I; Koprivanacz K; Szeder B; Dülk M; Kudlik G; Vas V; Cserkaszky A; Sipeki S; Nyitray L; Vértessy BG; Buday L
J Biol Chem; 2019 Mar; 294(12):4608-4620. PubMed ID: 30659095
[TBL] [Abstract][Full Text] [Related]
8. Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells.
Yuan T; Wang Y; Zhao ZJ; Gu H
J Biol Chem; 2010 May; 285(20):14861-14870. PubMed ID: 20335174
[TBL] [Abstract][Full Text] [Related]
9. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Src kinase SH3 binding site in the C-terminal domain of the human ErbB2 receptor tyrosine kinase.
Bornet O; Nouailler M; Feracci M; Sebban-Kreuzer C; Byrne D; Halimi H; Morelli X; Badache A; Guerlesquin F
FEBS Lett; 2014 Jun; 588(12):2031-6. PubMed ID: 24815698
[TBL] [Abstract][Full Text] [Related]
11. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression.
Stevenson LE; Frackelton AR
Breast Cancer Res Treat; 1998 May; 49(2):119-28. PubMed ID: 9696394
[TBL] [Abstract][Full Text] [Related]
12. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
Zhan L; Xiang B; Muthuswamy SK
Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444
[TBL] [Abstract][Full Text] [Related]
13. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.
Nagy P; Vereb G; Sebestyén Z; Horváth G; Lockett SJ; Damjanovich S; Park JW; Jovin TM; Szöllosi J
J Cell Sci; 2002 Nov; 115(Pt 22):4251-62. PubMed ID: 12376557
[TBL] [Abstract][Full Text] [Related]
14. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM
J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7.
Janes PW; Lackmann M; Church WB; Sanderson GM; Sutherland RL; Daly RJ
J Biol Chem; 1997 Mar; 272(13):8490-7. PubMed ID: 9079677
[TBL] [Abstract][Full Text] [Related]
16. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
Ishizawar RC; Miyake T; Parsons SJ
Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
[TBL] [Abstract][Full Text] [Related]
17. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.
Friedländer E; Arndt-Jovin DJ; Nagy P; Jovin TM; Szöllosi J; Vereb G
Cytometry A; 2005 Oct; 67(2):161-71. PubMed ID: 16163699
[TBL] [Abstract][Full Text] [Related]
19. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.
Mineev KS; Bocharov EV; Pustovalova YE; Bocharova OV; Chupin VV; Arseniev AS
J Mol Biol; 2010 Jul; 400(2):231-43. PubMed ID: 20471394
[TBL] [Abstract][Full Text] [Related]
20. Star-related lipid transfer protein 10 (STARD10): a novel key player in alcohol-induced breast cancer progression.
Floris A; Luo J; Frank J; Zhou J; Orrù S; Biancolella M; Pucci S; Orlandi A; Campagna P; Balzano A; Ramani K; Tomasi ML
J Exp Clin Cancer Res; 2019 Jan; 38(1):4. PubMed ID: 30611309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]